| Literature DB >> 17049610 |
Donghua Hu1, Chen Shao, Wei Guan, Zhongmin Su, Jiazhong Sun.
Abstract
Ti-containing alpha-Keggin polyoxometalates (POMs) have been proved with properties of both anti-tumor and anti-HIV (human immunodeficiency virus). The potential anti-SARS (severe acute respiratory syndrome) activity of the POMs [alpha-PTi(2)W(10)O(40)](7-) isomers was investigated in this paper by molecular modeling method. The SARS 3c like protease, namely the SARS 3CL(pro) is the key function protease for virus replication as well as transcription and thus can be taken as one of the key targets for anti-SARS drug design. Affinity/Insight II was used to explore possible binding locations for POMs/3CL(pro) interaction. Charges in the POMs were obtained from density-functional theory (DFT) method. The results show that POMs bind with 3CL(pro) in the active site region with high affinity; POMs are more prone to bind with 3CL(pro) than with some organic compounds; for the POMs/3CL(pro)complex, the OTi(2) in POMs is the vital element for electrostatic interaction, and the electrostatic binding energy is strong enough to keep the complex stable.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17049610 PMCID: PMC7112571 DOI: 10.1016/j.jinorgbio.2006.08.013
Source DB: PubMed Journal: J Inorg Biochem ISSN: 0162-0134 Impact factor: 4.155
Fig. 1The equilibrated conformation in solution of SARS 3CLpro dimer. The catalytic residues of Cys145 and His41 are represented in ball-and-stick.
Fig. 2Profile-3D evaluation of the SARS-CoV 3CLpro model.
Fig. 3The three-dimensional structural models of the five [α-PTi2W10O40]7− POMs.
Fig. 4The representative structure of POM/SARS-CoV 3CLpro complex. The 3CLpro is represented in cartoon, while binding site and POM are represented in ball-and-stick.
Binding energy between ligand and receptor (KJ/mol)
| EPot | ENonb | ||||
|---|---|---|---|---|---|
| 3CLpro | −9728.458 | −13646.040 | |||
| 1,2-PTi2/3CLpro | −9690.838 | 37.620 | −13755.647 | −109.607 | −71.987 |
| 1,4-PTi2/3CLpro | −9689.251 | 39.207 | −13753.616 | −107.576 | −68.369 |
| 1,11-PTi2/3CLpro | −9688.869 | 39.589 | −13748.752 | −102.712 | −63.123 |
| 1,5-PTi2/3CLpro | −9691.295 | 37.163 | −13749.754 | −103.714 | −66.551 |
| 1,6-PTi2/3CLpro | −9691.009 | 37.449 | −13749.227 | −103.187 | −65.738 |
Note: Δ is the energy change originating from the steric hindrance.
Δ1 is the energy change of electrostatic energy.
Δ2 is the total energy change of electrostatic energy plus steric hindrance.
Binding site and H-bond formation (H-bond length: Å)
| Complex | 3CLpro residue | Ligand atom | Distance |
|---|---|---|---|
| 1,2-PTi2/3CLpro | A46:O | O11 | 2.29 |
| A145:O | O16 | 2.75 | |
| A164:O | O22 | 1.75 | |
| A41:ND1 | O22 | 2.87 | |
| A41:ND1 | O23 | 1.40 | |
| A41:ND1 | O25 | 2.56 | |
| A189:OE1 | O28 | 0.76 | |
| A26:O | O41 | 1.96 | |
| 1,4-PTi2/3CLpro | A166:O | O6 | 2.04 |
| A41:HE2 | O20 | 2.11 | |
| A166:OE2 | O44 | 2.98 | |
| A41:ND1 | O47 | 2.35 | |
| A143:O | O50 | 1.84 | |
| A145:HN | O50 | 2.47 | |
| 1,11-PTi2/3CLpro | A25:OG1 | O12 | 1.47 |
| A41:O | O12 | 2.96 | |
| A26:O | O19 | 2.51 | |
| A187:O | O22 | 2.92 | |
| A166:O | O27 | 2.86 | |
| A142:OD1 | O42 | 2.51 | |
| 1,5-PTi2/3CLpro | A119:OD1 | O9 | 2.37 |
| A145:HN | O9 | 2.13 | |
| A166:OE1 | O19 | 1.39 | |
| A26:O | O22 | 1.44 | |
| A46:O | O29 | 1.69 | |
| A41:O | O36 | 1.48 | |
| A164:O | O39 | 1.92 | |
| A166:O | O42 | 2.76 | |
| A41:HE2 | O43 | 2.07 | |
| 1,6-PTi2/3CLpro | A25:O | O45 | 2.28 |
| A26:O | O52 | 2.13 | |
| A26:HN | O39 | 0.67 | |
| A41:O | O50 | 2.53 | |
| A41:ND1 | O42 | 2.65 | |
| A41:HE2 | O33 | 1.96 | |
| A44:O | O47 | 2.93 | |
| A142:O | O48 | 2.84 |
Fig. 5Key residues and hydrogen bond interactions of POM/3CLpro complex.